Ketorolac Injections for Musculoskeletal Conditions: A Narrative Review.

Andres I Applewhite, George G A Pujalte, John Kiel, Tais G O Bertasi, Raphael A O Bertasi, LaRae L Seemann, Lorena M C Costa, Haytham Helmi

Journal: Clinical medicine & research 2024;22(1):19-27

PMID: 38609144

Abstract

Musculoskeletal conditions of the upper and lower extremities are commonly treated with corticosteroid injections. Ketorolac, a parenteral nonsteroidal anti-inflammatory drug, represents an alternative injectant for common shoulder, hip, and knee conditions. A review of the current literature was conducted on the efficacy of ketorolac injection in musculoskeletal diseases. Several studies support the use and efficacy of ketorolac injection in subacromial bursitis, adhesive capsulitis, and hip and knee osteoarthritis. Given the systemic effects of glucocorticoid injections, ketorolac may be a safe and effective alternative in patients with musculoskeletal disease. However, more evidence is required to better understand the effects ketorolac has on the human body during inflammatory processes.

Copyright © 2024 Marshfield Clinic Health System.

Address: Department of Emergency Medicine, University of Florida, Jacksonville, Florida.; Department of Sports Medicine, University of Florida, Jacksonville, Florida.; Department of Family Medicine, Mayo Clinic, Jacksonville, Florida.; Department of Medicine, Mount Sinai Morningside-West, New York, New York.; Department of Family Medicine, Mayo Clinic, Jacksonville, Florida.; Current affiliation: Department of Pathology at Atrium Health, Wake Forest Baptist, Winston-Salem, North Carolina.; Department of Emergency Medicine, University of Florida, Jacksonville, Florida.; Department of Family Medicine, Mayo Clinic, Jacksonville, Florida [email protected].; Division of Sports Medicine, Mayo Clinic, Jacksonville, Florida.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.